VA

Healthcare · Pharmaceuticals

Valiant Laboratories Ltd (VALIANTLAB)

₹94.91

Mkt cap
₹493 Cr
P/E ratio
30.40
P/B
1.55
Div yield
0.00%
ROE
−2.55%
ROCE
0.58%
EPS (TTM)
₹3.12
Book value
₹61
52W range
50–141
Sector
Healthcare

Price history

Previous close

Incorporated in 1980, Valiant Laboratories Ltd manufactures and deals in Pharmaceuticals and speciality chemicals [1]

NSE VALIANTLABBSE 543998
Health check
Cautious
ValuationFair
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−32.87% from high
₹95
₹50+91.70% from low₹141
Current
₹94.91
Prev close
₹96.84
Day
−1.99%
Price performance
1D
−1.99%
1W
−9.58%
1M
−27.58%
3M
+3.55%
6M
+24.93%
1Y
+19.26%
YTD
+36.78%

Financials

Revenue, profit & margin
P/E ratio
30.4×
VALIANTLAB is 6% below the sector median of 32.5×
VALIANTLAB30.4×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales59.5540.5230.5918.8821.4835.2357.7946.8246.2052.4691.98115.29116.77
YoY Sales growth-32.30%-42.74%-65.98%-63.28%-63.93%-13.06%+88.92%+147.99%+115.08%+48.91%+59.16%+146.24%+152.75%
Expenses60.9446.8335.1221.2728.2234.6153.9744.4346.1253.3587.1786.03111.59
Operating Profit-1.39-6.31-4.53-2.39-6.740.623.822.390.08-0.894.8129.265.18
OPM %-2.33%-15.57%-14.81%-12.66%-31.38%1.76%6.61%5.10%0.17%-1.70%5.23%25.38%4.44%
Other Income2.961.782.502.813.361.58-2.310.660.870.630.170.860.11
Interest0.020.020.020.050.010.060.050.070.140.681.011.070.96
Depreciation0.490.490.520.530.520.520.520.530.532.052.932.863.66
Profit before tax1.06-5.04-2.57-0.16-3.911.620.942.450.28-2.991.0426.190.67
Tax %25.47%-30.75%-51.75%218.75%21.23%-44.44%25.53%25.71%25.00%136.12%-68.27%19.43%37.31%
Net Profit0.79-3.50-1.24-0.51-4.742.350.701.820.20-7.061.7621.100.41
EPS in Rs0.23-0.75-0.26-0.11-1.010.500.150.390.04-1.300.323.880.08
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +1.50% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast10 Aug '26◦2 Nov '26◦
Earnings day+5.00%−1.99%
+1 day+10.25%−3.95%
+5 days+33.98%−13.16%
+15 days+35.02%—
+30 days+78.79%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
74.94%Promoter
Promoters74.94%
FIIs0.07%0.07
DIIs0.08%0.08
Public24.91%0.15
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.704,51,5380.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.071,78,1800.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.691,24,1950.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.481,19,9900.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.561,16,3600.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.881,14,5180.92%852−35.05%7,404−2.44%15.49%
Valiant Laborato₹94.9130.434930.00%0+105.00%117+152.75%0.58%
Median: 160 Co.₹432.2032.471,9870.08%13+33.73%179+21.23%14.94%

Filings